David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
Investors continue to show their ambivalence about solar power stocks, as every fresh quarterly report is met with a fresh round of aggressive buying or selling, Simply put, these companies are neither as good nor as bad as their quarterly reports imply. Instead, these reports highlight that the industry is… Read More
Israel, believe it or not, is a blossoming emerging market. That’s because the country has an obsession with technology. You could argue that Israel is more focused on technology than any other emerging market in the world. On a per capita basis, the country has the highest… Read More
There was once a company akin to a 10-year-old on a triple espresso high, an energetic beast that wouldn’t rest. Its stock had superior risk-adjusted returns. The company became a global brand. It redefined what people do with their free time, giving them a place to meet and hang out… Read More
Shares of asset manager Legg Mason (NYSE: LM) are up +11% today to an 18-month high, after delivering modest upside to first-quarter forecasts on Monday evening. Shares are likely getting such a strong boost from an announced restructuring plan that will take $150… Read More
After a strong run, it’s typical to see a stock chart start to flatten out as buyers and sellers move into equilibrium. More often than not, that’s a sign to take profits. Not only do fundamental measures often tell you that a stock is fairly valued at this point, but… Read More
The medical device sector is still reeling from the healthcare reform bill. Slapped with a 3% tax increase effective January 2013, many medical device manufacturers and distributors such as Medtronics (NYSE: MDT) and Stryker (NYSE: SYK) fear future sales and earnings… Read More
What do penguins in Antarctica and a company in Colorado have to do with the profits you can make on the New York Stock Exchange? More than you might think. Antarctica’s clusters of emperor penguins are spread across the 5.4 million square miles of… Read More
How many times have you walked through the aisles of your local grocery store and mindlessly grabbed items off the shelf that are staples of your home? Things like spaghetti sauce, dish soap, shampoo, paper towels… the little necessities life requires. How many times have you plucked… Read More
As European countries step up in support of Greece (and by extension the banks who are lending to that troubled country), it should come as no surprise that major European bank stocks are posting strong gains in Monday trading. Shares of Netherlands-based ING (NYSE:… Read More
Today’s market action is a rising tide that is lifting all boats. Well, almost all of them. Dean Foods (NYSE: DF), which makes a wide range of products found in the dairy section of supermarkets, hit a 52-week low after announcing that pricing pressures are forcing… Read More
